Estrogen_NN
receptor_NN
concentration_NN
and_CC
social_JJ
factors_NNS
as_IN
predictors_NNS
of_IN
natural_JJ
killer_NN
cell_NN
activity_NN
in_IN
early-stage_JJ
breast_NN
cancer_NN
patients_NNS
._.

Confirmation_NN
of_IN
a_DT
model_NN
._.

Previous_JJ
work_NN
of_IN
ours_PRP
has_VBZ
demonstrated_VBN
that_IN
a_DT
significant_JJ
amount_NN
of_IN
natural_JJ
killer_NN
-LRB-_-LRB-
NK_NN
-RRB-_-RRB-
activity_NN
variance_NN
after_IN
surgery_NN
in_IN
stage_NN
I_CD
and_CC
II_CD
breast_NN
cancer_NN
patients_NNS
could_MD
be_VB
accounted_VBN
for_IN
by_IN
both_CC
the_DT
estrogen_NN
receptor_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
status_NN
of_IN
the_DT
tumor_NN
and_CC
by_IN
social_JJ
factors_NNS
,_,
namely_RB
,_,
perceived_VBN
social_JJ
support_NN
and_CC
seeking_VBG
social_JJ
support_NN
as_IN
a_DT
general_JJ
coping_NN
strategy_NN
._.

As_IN
considerable_JJ
evidence_NN
has_VBZ
accumulated_VBN
that_IN
social_JJ
support_NN
in_IN
both_CC
animal_NN
and_CC
human_JJ
populations_NNS
may_MD
have_VB
survival_NN
value_NN
,_,
we_PRP
sought_VBD
to_TO
test_VB
the_DT
reliability_NN
of_IN
this_DT
regression_NN
model_NN
,_,
using_VBG
coping_NN
and_CC
perceived_VBN
support_NN
factor_NN
values_NNS
obtained_VBN
at_IN
3_CD
months_NNS
after_IN
surgery_NN
to_TO
account_VB
for_IN
concurrent_JJ
follow-up_JJ
NK_NN
activity_NN
in_IN
this_DT
serially_RB
assessed_VBN
group_NN
of_IN
patients_NNS
._.

It_PRP
was_VBD
found_VBN
that_IN
the_DT
most_RBS
significant_JJ
variable_NN
predicting_VBG
NK_NN
activity_NN
at_IN
follow-up_NN
was_VBD
tumor_NN
ER_NN
concentration_NN
,_,
with_IN
higher_JJR
NK_NN
activity_NN
associated_VBN
with_IN
ER_NN
-_TO
status_NN
._.

In_IN
addition_NN
,_,
seeking_VBG
social_JJ
support_NN
as_IN
a_DT
coping_NN
strategy_NN
,_,
as_RB
well_RB
as_IN
the_DT
perceived_VBN
quality_NN
of_IN
support_NN
,_,
also_RB
entered_VBD
the_DT
model_NN
to_TO
account_VB
for_IN
a_DT
significant_JJ
amount_NN
of_IN
NK_NN
activity_NN
variance_NN
-LRB-_-LRB-
multivariate_JJ
F_NN
=_JJ
5.25_CD
,_,
p_NN
less_JJR
than_IN
0.001_CD
-RRB-_-RRB-
._.

If_IN
,_,
as_IN
the_DT
literature_NN
suggests_VBZ
,_,
NK_NN
activity_NN
is_VBZ
relevant_JJ
to_TO
breast_NN
cancer_NN
control_NN
,_,
and_CC
since_IN
ER_NN
-_:
tumors_NNS
have_VBP
a_DT
worse_JJR
prognosis_NN
,_,
we_PRP
suggest_VBP
here_RB
that_IN
perhaps_RB
such_JJ
tumors_NNS
are_VBP
resistant_JJ
to_TO
control_VB
by_IN
NK_NN
cells_NNS
because_IN
they_PRP
lack_VBP
the_DT
ability_NN
to_TO
attract_VB
an_DT
accumulation_NN
of_IN
effector_NN
cells_NNS
to_TO
the_DT
tumor_NN
site_NN
,_,
or_CC
because_IN
blocking_VBG
factors_NNS
at_IN
the_DT
site_NN
of_IN
the_DT
tumor_NN
prevent_VBP
local_JJ
tumor_NN
control_NN
at_IN
the_DT
site_NN
of_IN
action_NN
._.

The_DT
finding_NN
related_JJ
to_TO
social_JJ
support_NN
also_RB
replicates_VBZ
results_NNS
from_IN
an_DT
independent_JJ
sample_NN
of_IN
breast_NN
cancer_NN
patients_NNS
._.

This_DT
finding_NN
,_,
taken_VBN
together_RB
with_IN
other_JJ
evidence_NN
that_IN
this_DT
social_JJ
variable_NN
is_VBZ
associated_VBN
with_IN
longer_JJR
survival_NN
in_IN
breast_NN
cancer_NN
populations_NNS
,_,
underscores_VBZ
the_DT
potential_JJ
importance_NN
of_IN
this_DT
social_JJ
support_NN
variable_NN
._.

Our_PRP$
findings_NNS
also_RB
suggest_VBP
one_CD
possible_JJ
immunological_JJ
variable_JJ
involved_VBN
,_,
with_IN
potential_JJ
clinical_JJ
significance_NN
,_,
for_IN
this_DT
patient_NN
population_NN
._.

